Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Psychoeducational Approach to Improve Health in Lupus [Phase 2]
This Phase 2 trial evaluating a psychoeducational approach to improve health in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)
The CASTLE study on cardiovascular risk assessment in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Zostavax in Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial evaluating Zostavax in patients with systemic lupus erythematosus has completed. The study, sponsored by the Oklahoma Medical …
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
A pooled analysis of BLISS-52 and BLISS-76 evaluates belimumab effectiveness in a subpopulation of systemic lupus erythematosus patients.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) [Phase 3]
Phase 3 pediatric trial APPLE studying atherosclerosis prevention in systemic lupus erythematosus has completed and posted results in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 study of belimumab in systemic lupus erythematosus has completed. The trial reported early safety, tolerability, and pharmacokinetic…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: The Role of ITGAM in Systemic Lupus Erythematosus
This clinical trial update investigates ITGAM (CD11b) in systemic lupus erythematosus. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus [Phase 4]
This open-label Phase 4 trial of Acthar Gel in adults with moderate to severe active systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Physical Therapy for Systemic Lupus Erythematosus (SLE) [NA]
The clinical trial evaluating physical therapy for systemic lupus erythematosus has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Safety of Estrogens in Lupus: Birth Control Pills [Phase 3]
Phase 3 trial update assessing the safety of estrogen-containing birth control pills in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Safety of Estrogens in Lupus: Hormone Replacement Therapy [Phase 3]
A Phase 3 trial evaluating the safety of estrogen-based hormone replacement therapy in systemic lupus erythematosus has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: A Study of AMG 557 in Adults With Systemic Lupus Erythematosus [Phase 1]
AMG 557 was evaluated in adults with systemic lupus erythematosus in a Phase 1 trial sponsored by Amgen; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: NOX-E36 First-in-Human (FIH) Study [Phase 1]
A first-in-human Phase 1 trial of NOX-E36 by TME Pharma has completed, reporting initial safety and tolerability data across inflammatory-re…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus [NA]
A completed clinical trial evaluating duloxetine for reducing pain in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
A Phase 1 safety study of CDP7657 was conducted in healthy volunteers and patients with systemic lupus erythematosus. The trial status is Co…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus [Phase 1]
Phase 1 safety and pharmacokinetic study of CNTO 136 in patients with cutaneous lupus erythematosus and systemic lupus erythematosus; the tr…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
A Phase 2 safety and efficacy study of belimumab (LymphoStat-B) in systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis [Phase 2, Phase 3]
Clinical trial update on the efficacy and safety of Tripterygium wilfordii for lupus nephritis across Phase 2 and Phase 3 studies. The curre…
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus [Phase 2]
Phase 2 clinical trial evaluating epratuzumab for systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease [Phase 2]
Open-label Phase 2 trial of epratuzumab in serologically-positive systemic lupus erythematosus with active disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus [Phase 1]
Phase 1 study assessing the safety and tolerability of multiple intravenous doses of MEDI-545 in adults with systemic lupus erythematosus ha…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Evaluation of the Influence of Food Regimen on Oshadi D Absorption [NA]
A completed clinical trial assessing how different food regimens affect the absorption of Oshadi D in systemic lupus erythematosus patients.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
A completed clinical trial evaluating genotype-guided, personalized dosing of cyclophosphamide for systemic lupus erythematosus, aiming to o…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) [Phase 3]
A Phase 3 trial of epratuzumab in systemic lupus erythematosus sponsored by UCB Pharma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Phase 2, Phase 3]
A Phase 2/3 efficacy and safety study of abatacept for lupus nephritis in systemic lupus erythematosus has been terminated, with results pos…